|

oral insulin Clinical Trials

1 actively recruiting trial

Also known as: SCD0503 high dose, SCD0503 low dose, SCD0503 medium dose

Pipeline

Phase 1: 1

Top Sponsors

  • Sam Chun Dang Pharm. Co. Ltd.1

Indications

Other1 trial

Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.